Point72 Asset Management
TYRA icon

Point72 Asset Management’s Tyra Biosciences TYRA Stock Holding History

Point72 Asset Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.9M Buy
+180,100
New +$5.83M 0.01% 1481

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Point72 Asset Management's TYRA Position: Q1 2026 in Review

Point72 Asset Management reduced its Tyra Biosciences (TYRA) stake by 96% in Q1 2026, selling an estimated $27M and leaving 38,850 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2507.

Point72 Asset Management first reported a position in TYRA in Q4 2024 and has held it in 6 quarters since. The position peaked at $23M in Q4 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Point72 Asset Management held 38,850 shares of Tyra Biosciences worth $1.49M as of Q1 2026.
  • Point72 Asset Management sold 835,342 Tyra Biosciences shares in Q1 2026, an estimated $27M.
  • Tyra Biosciences made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2507 holding.
  • Point72 Asset Management first reported a position in Tyra Biosciences in Q4 2024 and has held it in 6 quarters since.
  • Point72 Asset Management's Tyra Biosciences position peaked at $23M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.